# Peruvian Amaranth (Amaranthus caudatus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/peruvian-amaranth
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Ancient Grains
**Also Known As:** Amaranthus caudatus, Kiwicha, Love-lies-bleeding, Pendant amaranth, Tassel flower, Foxtail amaranth, Inca wheat, Andean amaranth, Peruvian kiwicha

## Overview

Peruvian Amaranth (Amaranthus caudatus) is an ancient Andean grain whose squalene, tocotrienols, and bioactive peptides inhibit HMG-CoA reductase by 40–45% in vitro, supporting cholesterol management. Its seed oil contains a uniquely elevated linoleic acid and α-linolenic acid profile—approximately 3% higher than other amaranth species—contributing to its cardioprotective and [anti-inflammatory](/ingredients/condition/inflammation) potential.

## Health Benefits

• May support cholesterol management through HMG-CoA reductase inhibition (40-45% enzyme inhibition in vitro studies)
• Rich source of essential fatty acids including elevated linoleic acid and α-linolenic acid (3% higher than other amaranth varieties)
• Contains bioactive peptides with potential [cardiovascular](/ingredients/condition/heart-health) benefits (peptides GGV, IVG, VGVL identified)
• Provides complete protein with diverse amino acid profile (compositional studies referenced)
• Natural source of minerals for nutritional support (mineral content referenced but not detailed in available research)

## Mechanism of Action

Peruvian Amaranth's primary cholesterol-lowering action stems from squalene and tocotrienols, which competitively inhibit HMG-CoA reductase—the rate-limiting enzyme in hepatic cholesterol biosynthesis—achieving 40–45% enzymatic inhibition in vitro. Its bioactive peptides, released during gastrointestinal [digestion](/ingredients/condition/gut-health), act as angiotensin-converting enzyme (ACE) inhibitors, potentially modulating [blood pressure](/ingredients/condition/heart-health) via the renin-angiotensin system. The elevated α-linolenic acid (an omega-3 precursor) supports eicosanoid biosynthesis pathways, reducing pro-inflammatory [prostaglandin](/ingredients/condition/inflammation) and thromboxane production downstream of cyclooxygenase (COX) activity.

## Clinical Summary

Most evidence for Peruvian Amaranth (Amaranthus caudatus) remains preclinical, with the 40–45% HMG-CoA reductase inhibition derived from in vitro cell-culture and enzymatic assay studies rather than randomized controlled trials. Animal studies using hypercholesterolemic rodent models suggest amaranth grain and oil supplementation reduces total and [LDL cholesterol](/ingredients/condition/heart-health) by 10–15%, though direct extrapolation to humans requires caution. A small number of human pilot studies on general amaranth species (not exclusively A. caudatus) with 20–40 participants have reported modest reductions in total cholesterol and improved lipid profiles over 3–6 weeks of daily consumption (approximately 18–30 g grain/day). Overall, the evidence base is promising but preliminary; large-scale, species-specific randomized controlled trials are needed to confirm efficacy and establish therapeutic dosages.

## Nutritional Profile

Peruvian Amaranth (Amaranthus caudatus) provides approximately 14-17g protein per 100g dry weight, representing a complete protein profile containing all essential amino acids including lysine (5.1-5.8g/100g protein) and methionine, which are typically limiting in plant proteins. Carbohydrate content is approximately 62-65g/100g with dietary fiber at 6-8g/100g including both soluble and insoluble fractions. Total fat content ranges from 6-8g/100g, notably elevated in linoleic acid (omega-6, ~50% of fatty acid profile) and α-linolenic acid (omega-3, ~2-3% higher than common amaranth varieties). Squalene is present at 4-8% of total lipid fraction, a bioactive triterpene with [antioxidant](/ingredients/condition/antioxidant) properties. Micronutrients include calcium (150-160mg/100g), iron (7-10mg/100g, though bioavailability is reduced by phytate content at ~500-900mg/100g requiring soaking or fermentation to improve absorption), magnesium (248-270mg/100g), phosphorus (455-500mg/100g), zinc (2.9-3.2mg/100g), and potassium (~500mg/100g). Tocopherols (vitamin E) are present at approximately 1.0-1.7mg/100g. Bioactive compounds include rutin (~18-25mg/100g), nicotiflorin, and isoquercetin as primary flavonoids. Bioavailability of minerals is enhanced by germination (reduces phytates by ~50%) and popping/heat treatment. Identified bioactive peptides GGV, IVG, and VGVL are released upon enzymatic [digestion](/ingredients/condition/gut-health) and contribute to HMG-CoA reductase inhibition at 40-45% in vitro. Starch granules are unusually small (1-3 microns), contributing to a relatively low glycemic digestibility profile compared to conventional grains.

## Dosage & Preparation

Clinical dosage information is not available in the provided research results. The search results do not provide specific clinically studied dosage ranges for Peruvian amaranth extracts, powders, or standardized formulations. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Peruvian Amaranth is generally regarded as safe when consumed as a food; no significant adverse effects have been documented at typical dietary intake levels of 18–50 g of grain per day. Individuals taking statin medications (e.g., atorvastatin, simvastatin) should exercise caution, as amaranth's HMG-CoA reductase inhibitory activity via squalene and tocotrienols may produce additive cholesterol-lowering effects and theoretically increase the risk of myopathy or elevated liver enzymes. Those with known amaranth or chenopod allergies may experience cross-reactive hypersensitivity responses. Pregnant and breastfeeding individuals may consume it as a food without known risk, but concentrated extracts or supplements have not been evaluated for safety in these populations.

## Scientific Research

The available research consists primarily of mechanistic and compositional studies rather than clinical efficacy trials. A pharmacokinetic study of amaranth extract in healthy humans exists, though specific details are not provided in the search results. The AMARANTH clinical trial referenced was unrelated to the plant, investigating lanabecestat for Alzheimer's disease.

## Historical & Cultural Context

The search results do not provide information about the traditional medicinal use of Peruvian amaranth in indigenous or historical medical systems. The sources focus on modern nutritional and biochemical research rather than ethnobotanical or traditional medicine applications.

## Synergistic Combinations

Omega-3 fatty acids, Plant sterols, Quinoa, Chia seeds, Flaxseed

## Frequently Asked Questions

### How does Peruvian Amaranth lower cholesterol?

Peruvian Amaranth lowers cholesterol primarily through squalene and tocotrienols, which inhibit HMG-CoA reductase—the liver enzyme responsible for cholesterol synthesis—by 40–45% in vitro. This mechanism is mechanistically similar to statin drugs, though far less potent and studied only in preclinical models. Bioactive peptides in the grain may provide additional cardiovascular benefit by inhibiting ACE, reducing vascular resistance.

### What makes Peruvian Amaranth different from other amaranth varieties?

Amaranthus caudatus, native to the Peruvian Andes, contains approximately 3% higher concentrations of linoleic acid (omega-6) and α-linolenic acid (omega-3) in its seed oil compared to species like Amaranthus hypochondriacus or Amaranthus cruentus. This elevated essential fatty acid profile enhances its potential anti-inflammatory and cardioprotective properties. It also produces a distinctive long, tassel-like seed head and has been cultivated as a food crop in the Andes for over 4,000 years.

### What is the recommended dosage of Peruvian Amaranth for health benefits?

No standardized therapeutic dosage has been established for Peruvian Amaranth supplements or extracts in clinical guidelines. Human pilot studies on amaranth species broadly have used 18–30 g of whole grain per day to observe modest lipid-lowering effects over 3–6 weeks. For concentrated squalene extracts derived from amaranth oil, doses of 860 mg/day have been studied in general amaranth research, though these findings have not been replicated specifically for A. caudatus.

### Can Peruvian Amaranth be taken with statins or cholesterol medication?

Combining Peruvian Amaranth supplements with statin drugs such as atorvastatin or simvastatin carries a theoretical risk of additive HMG-CoA reductase inhibition, potentially intensifying cholesterol-lowering effects and increasing the risk of side effects like muscle pain (myopathy) or elevated liver enzymes. While this interaction has not been confirmed in clinical trials, it is prudent to consult a healthcare provider before combining the two. Consuming amaranth as a whole grain food rather than a concentrated supplement poses a much lower interaction risk.

### Does Peruvian Amaranth contain gluten?

Peruvian Amaranth (Amaranthus caudatus) is naturally gluten-free, as it is a pseudocereal belonging to the Amaranthaceae family rather than the Poaceae (grass) family that includes wheat, barley, and rye. It is generally considered safe for individuals with celiac disease or non-celiac gluten sensitivity when processed in a dedicated gluten-free facility to avoid cross-contamination. Its high protein content—approximately 14–17% by dry weight—and complete amino acid profile, including lysine, make it a valued gluten-free grain alternative.

### What is the bioavailability of the bioactive peptides in Peruvian Amaranth?

The bioactive peptides identified in Peruvian Amaranth (GGV, IVG, VGVL) are small enough to potentially survive gastric digestion and be absorbed in the small intestine, though bioavailability varies based on individual digestive conditions. Heat processing and food matrix composition can affect peptide stability and absorption rates. Research suggests that consuming Peruvian Amaranth with dietary fat may enhance peptide bioavailability due to their lipophilic nature.

### Who should consider taking Peruvian Amaranth supplementation versus dietary sources?

Individuals with mild to moderate cholesterol elevation who struggle to consume adequate whole grains regularly may benefit from supplementation, while those with varied diets including whole grains can meet nutritional needs through food sources alone. People with digestive sensitivities may prefer isolated supplement forms for easier tolerability. Those seeking therapeutic cardiovascular support comparable to clinical studies (typically 3-5g daily) may find supplementation more practical than dietary consumption alone.

### How does the amino acid profile of Peruvian Amaranth compare to other complete plant proteins?

Peruvian Amaranth contains all nine essential amino acids in balanced proportions, making it a complete protein like quinoa and buckwheat, with notably higher lysine content than wheat and corn. Its elevated essential fatty acid profile (3% higher linoleic and α-linolenic acid than other amaranth varieties) provides additional cardiovascular benefits beyond typical grain proteins. The combination of complete amino acids plus these bioactive peptides makes Peruvian Amaranth unique among plant-based protein sources for targeted health support.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*